You have access
Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients
IGOR KISS, JITKA MLCOCHOVA, ZBYNEK BORTLICEK, ALEXANDR POPRACH, JIRI DRABEK, PETRA VYCHYTILOVA-FALTEJSKOVA, MAREK SVOBODA, TOMAS BUCHLER, STANISLAV BATKO, ALES RYSKA, MARIAN HAJDUCH and ONDREJ SLABY
Anticancer Research September 2016, 36 (9) 4955-4959;
